[go: up one dir, main page]

FR2929511B1 - Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes. - Google Patents

Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.

Info

Publication number
FR2929511B1
FR2929511B1 FR0852191A FR0852191A FR2929511B1 FR 2929511 B1 FR2929511 B1 FR 2929511B1 FR 0852191 A FR0852191 A FR 0852191A FR 0852191 A FR0852191 A FR 0852191A FR 2929511 B1 FR2929511 B1 FR 2929511B1
Authority
FR
France
Prior art keywords
fibroblasts
proliferation
activity
active principle
new active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0852191A
Other languages
English (en)
Other versions
FR2929511A1 (fr
Inventor
Delphine Rival
Valerie Andre
Louis Lamy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Priority to FR0852191A priority Critical patent/FR2929511B1/fr
Priority to KR1020107024555A priority patent/KR20100135871A/ko
Priority to JP2011502240A priority patent/JP2011519353A/ja
Priority to PCT/EP2008/057372 priority patent/WO2009121422A1/fr
Priority to EP20080774074 priority patent/EP2273973A1/fr
Priority to US12/935,965 priority patent/US8460721B2/en
Publication of FR2929511A1 publication Critical patent/FR2929511A1/fr
Application granted granted Critical
Publication of FR2929511B1 publication Critical patent/FR2929511B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0852191A 2008-04-02 2008-04-02 Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes. Expired - Fee Related FR2929511B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0852191A FR2929511B1 (fr) 2008-04-02 2008-04-02 Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.
KR1020107024555A KR20100135871A (ko) 2008-04-02 2008-06-12 섬유모세포의 증식 및/또는 활성을 자극하는 활성 성분
JP2011502240A JP2011519353A (ja) 2008-04-02 2008-06-12 線維芽細胞の増殖および／または活性を刺激する活性成分
PCT/EP2008/057372 WO2009121422A1 (fr) 2008-04-02 2008-06-12 Principe actif qui stimule la prolifération et/ou l'activité des fibroblastes
EP20080774074 EP2273973A1 (fr) 2008-04-02 2008-06-12 Principe actif qui stimule la prolifération et/ou l'activité des fibroblastes
US12/935,965 US8460721B2 (en) 2008-04-02 2008-06-12 Active ingredient that stimulates the proliferation and/or activity of fibroblasts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852191A FR2929511B1 (fr) 2008-04-02 2008-04-02 Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.

Publications (2)

Publication Number Publication Date
FR2929511A1 FR2929511A1 (fr) 2009-10-09
FR2929511B1 true FR2929511B1 (fr) 2010-12-31

Family

ID=40076926

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0852191A Expired - Fee Related FR2929511B1 (fr) 2008-04-02 2008-04-02 Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.

Country Status (6)

Country Link
US (1) US8460721B2 (fr)
EP (1) EP2273973A1 (fr)
JP (1) JP2011519353A (fr)
KR (1) KR20100135871A (fr)
FR (1) FR2929511B1 (fr)
WO (1) WO2009121422A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008054118A1 (de) * 2008-10-31 2010-05-06 Henkel Ag & Co. Kgaa Wirkstoffkombination zur Behandlung reifer Haut I
DE102008054117A1 (de) * 2008-10-31 2010-05-06 Henkel Ag & Co. Kgaa Wirkstoffkombination zur Behandlung reifer Haut II
KR101250841B1 (ko) 2010-10-20 2013-04-04 주식회사 엘지화학 경사 변곡점의 위치 변경에 의해 균일한 냉각 효율성을 가진 전지팩
WO2012121428A1 (fr) * 2011-03-07 2012-09-13 주식회사 웰스킨 Composition pour la croissance de fibroblastes comprenant un dipeptide à titre de principe actif, et produit la contenant
US9233062B2 (en) * 2011-05-10 2016-01-12 Mary Kay Inc. Cosmetic compositions
FR2976587B1 (fr) 2011-06-20 2015-04-03 Basf Beauty Care Solutions F Methode de dosage in vitro par technique immunologique
FR2993182B1 (fr) * 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
FR2997406B1 (fr) 2012-10-25 2015-07-03 Basf Beauty Care Solutions F Polymere de hyaluronate et de glucomannane
FR3000488B1 (fr) 2012-12-27 2015-10-02 Basf Beauty Care Solutions F Nouveaux derives de l'acide sinapique et leurs utilisations cosmetiques ou pharmaceutiques
RU2015132368A (ru) * 2013-02-19 2017-03-27 Данон, С.А. Функциональные пептиды для расстройств, связанных с ожирением
KR101638551B1 (ko) * 2014-07-10 2016-07-12 (주)제니트리 피부미백 및 피부주름 개선용 조성물, 이를 이용한 피부미백 및 피부주름 개선제의 제조방법 및 이를 포함하는 피부 외용제
KR101967793B1 (ko) * 2015-08-17 2019-08-14 학교법인연세대학교 락토바실러스 파라카제이 ｍｋ１을 이용한 주름개선용 화장료 조성물 및 그 제조방법
GB2543822A (en) * 2015-10-30 2017-05-03 Boots Co Plc Skin care composition and method thereof
CN105687110B (zh) * 2016-03-11 2018-12-04 千草万木（北京）科技有限公司 一种消除妊娠纹植物提取组合物及其在化妆品中的应用
FR3058641B1 (fr) 2016-11-17 2019-11-01 Basf Beauty Care Solutions France Sas Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees
JP6807535B2 (ja) * 2017-01-20 2021-01-06 ビーエイチエヌ株式会社 線維芽細胞増殖剤
CN107299004A (zh) * 2017-07-19 2017-10-27 福建德广中草药有限公司 一种可食用洗涤剂及其制作方法、应用
EP3539619A1 (fr) * 2018-03-15 2019-09-18 The Boots Company PLC Composition cosmétique concentrée
CN115243563B (zh) * 2020-03-06 2025-03-25 碧艾奇恩股份有限公司 用于抑制弹性蛋白酶的口服组合物及其应用、弹性蛋白酶抑制剂、口服摄入弹性蛋白酶抑制剂的抑制弹性蛋白酶活性的方法
JP7681193B2 (ja) * 2021-11-09 2025-05-21 イーエルシー マネージメント エルエルシー 化粧品組成物およびその使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1029922A (ja) * 1995-07-13 1998-02-03 Shiseido Co Ltd 皮膚外用剤
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
WO2002080862A1 (fr) * 2001-04-06 2002-10-17 Toyo Hakko Co., Ltd. Materiaux cosmetiques et leur procede de production
FR2834718B1 (fr) * 2002-01-15 2004-12-24 Cognis France Sa Substances actives cosmetiques et/ou pharmaceutiques
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
JP4558363B2 (ja) * 2003-06-19 2010-10-06 日本メナード化粧品株式会社 香料組成物
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
DE102005063062A1 (de) * 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut

Also Published As

Publication number Publication date
FR2929511A1 (fr) 2009-10-09
JP2011519353A (ja) 2011-07-07
US8460721B2 (en) 2013-06-11
US20110052739A1 (en) 2011-03-03
WO2009121422A1 (fr) 2009-10-08
EP2273973A1 (fr) 2011-01-19
KR20100135871A (ko) 2010-12-27

Similar Documents

Publication Publication Date Title
FR2929511B1 (fr) Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.
EP2131848A4 (fr) Compositions et methodes de potentialisation de l'activite de molecules biologiquement actives
EP2629799A4 (fr) Base topique et compositions contenant un principe actif, et procédés d'amélioration et de traitement de la peau
SMT201600273B (it) Genz 112638 per trattare la malattia di gaucher o fabry in terapia di combinazione
BR112013013790A2 (pt) compostos heterocíclos nitrogenosos 6,6-fundidos substituídos e usos dos mesmos
EP1850843A4 (fr) Inhibiteurs d'activite d'akt
EP1784175A4 (fr) Inhibiteurs de l'activite de akt
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
BRPI1013498A2 (pt) "combinações de leveduras e fungicidas com atividade fungicida ativa"
ATE447559T1 (de) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
EP1737861A4 (fr) Inhibiteurs de l'activite d'akt
EP2303269A4 (fr) Inhibiteurs de l'activité akt
EP2117523A4 (fr) Inhibiteurs de l'activité de akt
BRPI0816234A2 (pt) Derivado de ácido ascórbico ou sal do mesmo, método de produção do mesmo, e cosmético
EP2299825A4 (fr) Inhibiteurs de l'activité akt
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
EP2348018A4 (fr) Dérivé biarylique hétérocyclique et inhibiteur de pde le renfermant en tant qu'ingrédient actif
ATE461923T1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
CY1116840T1 (el) Χρηση 24-norudca
UA114304C2 (uk) Спосіб зниження сироваткових рівнів сечової кислоти у людини
IL220318A (en) Aqueous solutions comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart diseases
EP2351753A4 (fr) Dérivé de phénanthroindolizidine et inhibiteur de nf b le contenant en tant que principe actif
EP1871376A4 (fr) Inhibiteur de l'activite akt

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20241205